Viewing Study NCT05554003


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2025-12-28 @ 5:37 PM
Study NCT ID: NCT05554003
Status: RECRUITING
Last Update Posted: 2024-11-18
First Post: 2022-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
Sponsor: European Institute of Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module